Search

Author/Creator Zhu, Xudong

5. Activatable Protein Nanoparticles for Targeted Delivery of Therapeutic Peptides. Issue 49 (3rd December 2018)

Authors:
Yu, Xi; Gou, Xingchun; Wu, Peng; Han, Liang; Tian, Daofeng; Du, Fengyi; Chen, Zeming; Liu, Fuyao; Deng, Gang; Chen, Ann T.; Ma, Chao; Liu, Jun; Hashmi, Sara M.; Guo, Xing; Wang, Xiaolong; Zhao, Haitian; Liu, Xinran; Zhu, Xudong; Sheth, Kevin; Chen, Qianxue
Journal:
Advanced materials
Issue:
Volume 30:Issue 49(2018)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Activatable Protein Nanoparticles for Targeted Delivery of Therapeutic Peptides. Issue 7 (8th January 2018)

Authors:
Yu, Xi; Gou, Xingchun; Wu, Peng; Han, Liang; Tian, Daofeng; Du, Fengyi; Chen, Zeming; Liu, Fuyao; Deng, Gang; Chen, Ann T.; Ma, Chao; Liu, Jun; Hashmi, Sara M.; Guo, Xing; Wang, Xiaolong; Zhao, Haitian; Liu, Xinran; Zhu, Xudong; Sheth, Kevin; Chen, Qianxue
Journal:
Advanced materials
Issue:
Volume 30:Issue 7(2018)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. AKR1C3 expression in primary lesion rebiopsy at the time of metastatic castration‐resistant prostate cancer is strongly associated with poor efficacy of abiraterone as a first‐line therapy. Issue 13 (11th July 2019)

Authors:
Zhao, Jinge; Zhang, Mengni; Liu, Jiandong; Liu, Zhenhua; Shen, Pengfei; Nie, Ling; Guo, Wenhao; Cai, Diming; Liu, Jiyan; Armstrong, Cameron M.; Sun, Guangxi; Chen, Junru; Zhu, Sha; Dai, Jindong; Zhang, Haoran; Zhao, Peng; Zhang, Xingming; Yin, Xiaoxue; Zhu, Xudong; Ni, Yuchao
Journal:
Prostate
Issue:
Volume 79:Issue 13(2019)
Page Start:
1553
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗